Jean-Matthieu L'Orphelin

10PUBLICATIONS
16CO-AUTHORS
Water treatment processesCancer therapy (excl. chemotherapy and radiation therapy)AllergyMedical bacteriologyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 01, 2026
Sensoriality of emollient creams: can sensory experience compromise blinding in trials?

|Nov 24, 2025
Benefit of immune checkpoint inhibitors as adjuvant treatment for acral melanomas.

Damien Sanogo, Romain Levard, Julie Cassecuel

|Jul 09, 2025
Skin Rash on Immunotherapy: When Trombicula Mimics a Cutaneous Immune-related Adverse Event.

Léa Frigout, Taha Tagmouti, Pierre Goineau

|Feb 27, 2025
The Skin Microbiome: A New Key Player in Melanoma, From Onset to Metastatic Stage.

Jean-Matthieu L'Orphelin, Anne Dompmartin, Brigitte Dréno

|Dec 03, 2024
Immune checkpoint inhibitor rechallenge after immune-related adverse events: a retrospective study from VigiBase update in 2024 looking for emergent safety signals.

Jean-Matthieu L'Orphelin, Angélique Da Silva, Jean Cabon

|Nov 07, 2024
NIVO-TIL: combination anti-PD-1 therapy and adoptive T-cell transfer in untreated metastatic melanoma: an exploratory open-label phase I trial.

Jean-Matthieu L'Orphelin, Ugo Lancien, Jean-Michel Nguyen

Pageof 2

Frequent Collaborators

3 joint publications

Brigitte Dréno

1 joint publications

M H Junejo

1 joint publications

Z Appalla

1 joint publications

G Pellacani